Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53.9M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
56.6M
-
Shares change
-
+2.99M
-
Total reported value, excl. options
-
$542M
-
Value change
-
+$28.8M
-
Number of buys
-
79
-
Number of sells
-
-34
-
Price
-
$9.57
Significant Holders of Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) as of Q2 2025
137 filings reported holding TYRA - Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.6M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (12.2M shares), Alta Partners Management Company, L.P. (4.08M shares), Nextech Invest, Ltd. (4.06M shares), BVF INC/IL (3.94M shares), Canaan Partners XI LLC (3.61M shares), Commodore Capital LP (3.1M shares), TCG Crossover Management, LLC (2.9M shares), JANUS HENDERSON GROUP PLC (2.86M shares), Vestal Point Capital, LP (2.66M shares), and Kynam Capital Management, LP (2.33M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.